Obesity-associated activation of angiotensin and endothelin in the cardiovascular system

被引:91
作者
Barton, M
Carmona, R
Ortmann, J
Krieger, JE
Traupe, T
机构
[1] Univ Zurich Hosp, Dept Internal Med, Med Policlin, CH-8091 Zurich, Switzerland
[2] Univ Sao Paulo, Sch Med, Inst Heart, InCor,Lab Genet & Mol Cardiol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
diet; adipocyte; blood pressure; vasoconstriction; angiotensin converting enzyme; kidney; vascular; leptin; resistin; adiponectin;
D O I
10.1016/S1357-2725(02)00307-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The renin-angiotensin system (RAS) and the endothelin system have been implicated in the pathogenesis of human cardiovascular and renal diseases, and inhibition of the RAS markedly improves morbidity and survival. Obesity in humans is associated with an increased risk for the development of hypertension, atherosclerosis and focal-segmental glomerulosclerosis, however the exact mechanisms underlying these pathologies in obese individuals are not known. This article discusses the clinical importance of obesity and the current evidence for local activation of the renin-angiotensin system and its interactions with the endothelin system in obesity and the cardiovascular pathologies associated with it. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:826 / 837
页数:12
相关论文
共 114 条
[1]   Angiotensinogen, angiotensin II and adipose tissue development [J].
Ailhaud, G ;
Fukamizu, A ;
Massiera, F ;
Negrel, R ;
Saint-Marc, P ;
Teboul, M .
INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (Suppl 4) :S33-S35
[2]   Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Maeda, K ;
Kuriyama, H ;
Okamoto, Y ;
Kumada, M ;
Hotta, K ;
Nishida, M ;
Takahashi, M ;
Nakamura, T ;
Shimomura, I ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
CIRCULATION, 2002, 105 (24) :2893-2898
[3]   Exercise enhances vasorelaxation in experimental obesity associated hypertension [J].
Arvola, P ;
Wu, XM ;
Kähönen, M ;
Mäkynen, H ;
Riutta, A ;
Mucha, I ;
Solakivi, T ;
Kainulainen, H ;
Pörsti, I .
CARDIOVASCULAR RESEARCH, 1999, 43 (04) :992-1002
[4]   Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects - The Ohasama study [J].
Asai, T ;
Ohkubo, T ;
Katsuya, T ;
Higaki, J ;
Fu, YX ;
Fukuda, M ;
Hozawa, A ;
Matsubara, M ;
Kitaoka, H ;
Tsuji, I ;
Araki, T ;
Satoh, H ;
Hisamichi, S ;
Imai, Y ;
Ogihara, T .
HYPERTENSION, 2001, 38 (06) :1321-1324
[5]   ETA receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension [J].
Barton, M ;
d'Uscio, LV ;
Shaw, S ;
Meyer, P ;
Moreau, P ;
Lüscher, TF .
HYPERTENSION, 1998, 31 (01) :499-504
[6]   Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: Role of ETA receptors for endothelin regulation [J].
Barton, M ;
Shaw, S ;
dUscio, LV ;
Moreau, P ;
Luscher, TF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (03) :861-865
[7]   Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo -: Evidence for a regulatory role of endothelin [J].
Barton, M ;
Carmona, R ;
Morawietz, HM ;
d'Uscio, LV ;
Goettsch, W ;
Hillen, H ;
Haudenschild, CC ;
Krieger, JE ;
Münter, K ;
Lattmann, T ;
Lüscher, TF ;
Shaw, S .
HYPERTENSION, 2000, 35 (01) :329-336
[8]  
Barton M, 2002, NEW ENGL J MED, V346, P64
[9]   Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection? [J].
Barton, M .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (05) :789-809
[10]   TRANSGENIC MOUSE MODELS OF LIPOPROTEIN METABOLISM AND ATHEROSCLEROSIS [J].
BRESLOW, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8314-8318